Trademarkia Logo

Canada

C$
CIPHER
WITHDRAWN

Last Applicant/ Owned by

Repertoire Immune Medicines, Inc.

26 Landsdowne StreetCambridge MA 02139

US

Serial Number

2097822 filed on 1st Oct 2020

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

CIPHER

Trademark usage description

diagnostic kits comprised of diagnostic reagents and biological assays for use in fields of biological and diagnostic testing for clinical, medical, a Read More

Classification Information


Class [005]
Diagnostic kits comprised of diagnostic reagents and biological assays for use in fields of biological and diagnostic testing for clinical, medical, and medical laboratory research use, namely for testing of body fluids including blood and plasma, and cells; medical diagnostic reagents and assay components for testing of body fluids including blood and plasma, and cells.


Classification kind code

11

Class [042]
Scientific research in the fields of medical biotechnology, pharmaceutical biotechnology and development of pharmaceuticals; custom development of biochemical reagents and assays; scientific and technical consultation and product development for others in the field of biotechnology and development of pharmaceuticals


Classification kind code

11

Mark Details


Serial Number

2097822

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 4th Aug 2022
Search Recorded
Submitted for opposition 20
on 4th Aug 2022
Examiner's First Report
Submitted for opposition 223
on 4th Aug 2022
Total Provisional Refusal
Submitted for opposition 256
on 8th Feb 2022
Notification of Possible Opposition Sent
Submitted for opposition 48
on 25th May 2021
Agent Changed
Submitted for opposition 257
on 8th Apr 2021
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 7th Apr 2021
Created
Submitted for opposition 31
on 7th Apr 2021
Formalized
Submitted for opposition 228
on 1st Oct 2020
International Registration
Submitted for opposition 30
on 1st Oct 2020
Filed